For the third time in recent years, the option to legalize recreational cannabis will be placed before voters in the Mount Rushmore State.
On June 3, 2024, Measure 29 was approved by the Secretary of State Monae Johnson and will appear on the ballot in November (1,2). If passed by voters, cannabis would be legal for adults 21 years old and older for possession of up to two ounces of flower and 16 grams of concentrates (2). Additionally, private cultivation of up to six plants would be allowed (3). The Measure does not establish regulations for commercial sales or production of cannabis, though supporters of the Measure reportedly will collaborate with the Legislature to create the necessary regulations (1,3).
The initiative had been submitted by South Dakotans for Better Marijuana Laws, which is “a nonprofit political organization founded in 2019 that works to reform cannabis laws in South Dakota,” according to their website (4). The initiative review process began in December 2022, after the organization submitted the initiative with the Director of the South Dakota Legislative Research Council, then the second phase of review began in June 2023 once the initiative was filed with South Dakota Attorney General, South Dakota Secretary of State, and the Director of the South Dakota Legislative Research Council (4). In September 2023, it was approved for circulation (4).
Though cannabis for medical uses has been legal under certain circumstances since 2020 (5), recreational cannabis legalization has been on the ballot in the state two times in the past few years, both times failing to be fully passed or approved (1,3):
In comparison, cannabis for medical purposes has also experienced a rocky journey. Medical cannabis was approved in the state in 2020 with nearly 70% of voters in favor after two previous failed ballot measures, and sales of medical cannabis began in July 2022 (4). In July 2023, a South Dakotan activist submitted a proposal for a ballot initiative to repeal the state’s medical cannabis program (4).
The efforts to place recreational cannabis on the ballot has resulted in differing opinions.
Jim Kinyon, chairperson of the nonprofit Protecting South Dakota Kids, stated in an AP article covering the Measure 29 (1): “How many times does the state of South Dakota need to reject recreational marijuana before the industry will accept the decision of the state’s citizens? I expect that the industry will triple down on their money to try and sway and disuade voters.”
Zebadiah Johnson, campaign director supporting the legalization of cannabis, stated (1): “We firmly believe that South Dakotans deserve to make their own choices on how they live their lives, including the freedom to responsibly use cannabis.” Additionally, supporters from South Dakotans for Better Marijuana Laws believe that a presidential election year will result in higher voter turnout (3).
Recreational cannabis will also be on ballot in Florida this November, the initiative having been approved by the state’s Supreme Court in April 2024 (6). There, the proposed constitutional amendment will need approval from at least 60% of voters (6).
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.